Concepedia

James Degar

JD

5

Publications

251

Citations

5

H-Index

2018

Active since

Affiliations

Boston Children's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Medizinische Hochschule Hannover

Children's Hospital of Philadelphia

James Degar is an author at Boston Children's Hospital specializing in cell biology, medicine, and chromatin.

ORCID

Top concepts

Publications per year

2018–2022

5

Publications

5

Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

Laura Hinze, Maren Pfirrmann, Salmaan Karim et al. · Cancer Cell · 2019 · 103 citations · Full text

, , +9

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia

Ingrid M. Ariës, Kimberly Bodaar, Salmaan Karim et al. · The Journal of Experimental Medicine · 2018 · 59 citations · Full text

Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy

Laura Hinze, Roxane Labrosse, James Degar et al. · Cancer Discovery · 2020 · 57 citations · Full text

Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemia

Gayle P. Pouliot, James Degar, Laura Hinze et al. · PLoS ONE · 2019 · 20 citations · Full text

, , +11

Supramolecular assembly of GSK3α as a cellular response to amino acid starvation

Laura Hinze, Sabine Schreek, André Zeug et al. · Molecular Cell · 2022 · 12 citations · Full text

Rows per page

1–5 of 5